Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Shared Mechanism and Candidate Drugs of Multiple Sclerosis and Sjögren’s Syndrome Analyzed by Bioinformatics Based on GWAS and Transcriptome Data

9 Mar 2022

Abstract excerpt

Objective This study aimed to explore the shared mechanism and candidate drugs of multiple sclerosis (MS) and Sjögren’s syndrome (SS). Methods MS- and SS-related susceptibility genes and differentially expressed genes (DEGs) were identified by bioinformatics analysis based on genome-wide association studies (GWAS) and transcriptome data from GWAS catalog and Gene Expression Omnibus (GEO) database. Pathway...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multiple Sclerosis Research Studies
Share to Rheumatoid Arthritis Research and Therapies
Share to Salivary Gland Disorders and Functions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35356004
DOI: 10.3389/fimmu.2022.857014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Shared Mechanism and Candidate Drugs of Multiple Sclerosis and Sjögren’s Syndrome Analyzed by Bioinformatics Based on GWAS and Transcriptome DataPMID 35356004Read ↗

Establishment of comorbidity target pools and prediction of drugs candidate for multiple sclerosis and autoimmune thyroid diseases based on GWAS and transcriptome data.Semantic proximity Read ↗

Exploring of mechanisms and predicting of potential drugs of the comorbidity between migraine and multiple sclerosis based on bioinformatics analysis of transcriptome dataSemantic proximity Read ↗

Identification of candidate biomarkers and pathways associated with multiple sclerosis using bioinformatics and next generation sequencing data analysisSemantic proximity Read ↗

Hub genes, diagnostic model, and predicted drugs in systemic sclerosis by integrated bioinformatics analysisSemantic proximity Read ↗

Integrating network pharmacology and experimental validation to explore the key mechanism of artemisinin in treating primary Sjögren’s syndromeSemantic proximity Read ↗

Exploring shared genes and molecular mechanisms between primary Sjögren's syndrome and pulmonary hypertension based on transcriptome dataSemantic proximity Read ↗

Diagnostic markers and potential therapeutic agents for Sjögren’s syndrome screened through multiple machine learning and molecular dockingSemantic proximity Read ↗

Identifying Key Genes and Functionally Enriched Pathways in Sjögren’s Syndrome by Weighted Gene Co-Expression Network AnalysisSemantic proximity Read ↗

Identifying common genes, proteins, and pathways from human miRNA and gene blood profiles in multiple sclerosis patientsSemantic proximity Read ↗

The shared biomarkers and pathways of systemic lupus erythematosus and metabolic syndrome analyzed by bioinformatics combining machine learning algorithm and single-cell sequencing analysisSemantic proximity Read ↗

Drug Repositioning Identifies Six Drug Candidates for Systemic Autoimmune Diseases by Integrative Analyses of Transcriptomes from Scleroderma, Systemic Lupus Erythematosus, and Sjogren's SyndromeSemantic proximity Read ↗

Bioinformatics analyses of potentially common pathogenic networks for primary Sjogren’s syndrome complicated with acute myocardial infarctionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.